top of page


  • Writer's pictureTeam Archbow

Well-designed Access and Affordability Programs can be a Key Differentiator for Pharma Companies

Well-designed and Strategically Managed Access and Affordability Programs can be a Key Differentiator for Pharmaceutical Manufacturers

In today’s ultra-competitive market, biopharma manufacturers are consistently seeking advantages over competitive products. That mindset is a contributing factor to viewing manufacturer-sponsored access and affordability programs, long-standing staples of specialty drug market access strategies, in a new and expanded light.

Access and affordability programs, often called patient support programs or patient support services, may include reimbursement support, free drug via a Patient Support Program (PAP), copay programs, “HUBs”, clinical nursing support, and other services designed to eliminate hurdles HCPS, patients, and caregivers face when attempting to access prescribed medications.

Manufacturers, either bringing new products to market or optimizing existing product strategies, are now leveraging access and affordability programs as key differentiators designed to build brand loyalty through an elevated customer experience. In order to do that effectively, it’s essential for patient access teams to fully understand the evolving market landscape, competitive trends, and the unique needs of their product’s patient and prescriber population.

As a pharmaceutical consulting company, Archbow helps biopharma manufacturers design and build access and affordability strategies that create differentiation in the market. Our approach includes a customized mix of strategic and tactical methods, such as:

  • Exploring optimal pharmaceutical patient access and affordability approaches

  • Pharmaceutical market landscape assessments, including industry trends, competitive intelligence, analog research, real-world benchmarking, and market research

  • Strategic ideation and program solution design

  • Operations and technology assessments for pharmaceutical patient support programs

  • Pharmaceutical Fair Market Value assessments

  • Cost modeling for pharmaceutical programs

  • LOE market share loss prevention

  • Biosimilar strategies

  • RFP management and vendor selection (HUB, Copay, PAP, Non-commercial Dispensing, Clinical Nursing Support)

  • Program implementation and quality management

  • Data aggregation, reporting, and analytics

  • Program Optimization

Manufacturers need to approach access and affordability strategic planning in a way that is customized for their unique product and patient/prescriber populations. That’s where the right advisors, with unparalleled strategic and tactical experience, can make a genuine difference.

Learn more about our access and affordability team and the differentiators that matter most to manufacturers, and contact us today for assistance with your strategic and tactical patient and prescriber support needs.

See our work in action with these real-world case studies:

Keep reading with these related blog posts:


Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe reach their commercial goals with strategic and tactical approaches to distribution, pharmacy, and patient access. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn, Twitter or subscribing to this blog which you can do below.


bottom of page